WSM-28989-26751
3 vaccinations
3 coded responses
24 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 957 / CA
- Registered
- 2021-03-01
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Registered dependents
TSN-97608-41848
Child or adolescent in my care · Female · 2021-11-24
Timeline
-
2021-02-28
Dose 1 — Pfizer-BioNTech
-
2021-03-01
Registered in v-safe
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-14
-
2021-03-22
Dose 2 — Pfizer-BioNTech
- 2021-03-22
-
2021-03-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-07
- 2021-04-16
- 2021-04-21
-
2021-04-26
Survey response — day 35, dose 2MedDRA: Fatigue, Headache, Nasal congestion — Feeling: PoorFree text: Stuffy nose, fatigue, headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-03
-
2021-10-26
Dose 3 — Pfizer-BioNTech
-
2022-01-26
Survey response — 3 months, dose 3MedDRA: Palpitations — Feeling: GoodFree text: Heart palpitationsMedDRA releases: 2024-11 · check-in free text available
- 2022-04-26
-
2022-10-26
Survey response — 12 months, dose 3MedDRA: Alopecia, Pain of skin — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Hair loss and scalp painMedDRA releases: 2024-11 · check-in free text available
-
2022-10-26
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-28 | Pfizer-BioNTech | |
| 2 | 2021-03-22 | Pfizer-BioNTech | |
| 3 | 2021-10-26 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-26 | Unsuccessful |
Free text
Release 8 — day 35, dose 2
Symptoms: Stuffy nose, fatigue, headache
Release 11 — 3 months, dose 3
Symptoms: Heart palpitations
Release 12 — 12 months, dose 3
Symptoms: Hair loss and scalp pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Alopecia | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Pain of skin | · | · | ✓ |
| SD | Palpitations | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release